Skip to main content
Top

Open Access 06-04-2024 | Type 1 Diabetes | Original Research Article

Diabetes Research Matters: A Three-Round Priority-Setting Survey Consultation with Adults Living with Diabetes and Family Members in Australia

Authors: Christel Hendrieckx, Sienna Russell-Green, Timothy Skinner, Ashley H. Ng, Chris Lee, Siobhan Barlow, Alan Davey, Caitlin Rogers, Elizabeth Holmes-Truscott, Jane Speight

Published in: The Patient - Patient-Centered Outcomes Research

Login to get access

Abstract

Objective

We aimed to identify the health and quality-of-life research priorities of Australians with diabetes or family members.

Methods

Through an iterative, three-step, online survey process we (1) qualitatively generated research topics (long list) in response to one question “What research is needed to support people with diabetes to live a better life?”; (2) determined the most important research questions (short list); and (3) ranked research questions in order of importance (priorities). We aimed to recruit N = 800 participants, with approximate equal representation of diabetes type and family members.

Results

Participants (N = 661) were adults (aged 18+ years) in Australia with a self-reporting diagnosis of diabetes (type 1, n = 302; type 2, n = 204; prior/current gestational, n = 58; less common types, n = 22, or a family member, n = 75). Retention rates for Surveys 2 and 3 were 47% (n = 295) and 50% (n = 316), respectively. From 1549 open-text responses, 25 topics and 125 research questions were identified thematically. Research priorities differed by cohort, resulting in specific lists developed and ranked by each cohort. The top-ranked research question for the type 1 diabetes cohort was “How can diabetes technology be improved …?” and for the type 2 diabetes cohort: “How can insulin resistance be reversed …?”. One question was common to the final lists of all cohorts: “What are the causes or triggers of diabetes?” Within cohorts, the top priorities were perceived as being of similar importance.

Conclusions

The research priorities differ substantially by diabetes type and for family members. These findings should inform funding bodies and researchers, to align future research and its communication with community needs.
Appendix
Available only for authorised users
Literature
10.
go back to reference Begum M, Lewison G, Sommariva S, Ciani O, Tarricone R, Sullivan R. European diabetes research and its funding, 2002–2013. Diabet Med. 2017;34(10):1354–60.CrossRefPubMed Begum M, Lewison G, Sommariva S, Ciani O, Tarricone R, Sullivan R. European diabetes research and its funding, 2002–2013. Diabet Med. 2017;34(10):1354–60.CrossRefPubMed
12.
go back to reference Moses H, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–89.CrossRefPubMed Moses H, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–89.CrossRefPubMed
13.
go back to reference Jones A, Vallis M, Cooke D, Pouwer F. Review of research grant allocation to psychosocial studies in diabetes research. Diabet Med. 2016;33(12):1673–6.CrossRefPubMed Jones A, Vallis M, Cooke D, Pouwer F. Review of research grant allocation to psychosocial studies in diabetes research. Diabet Med. 2016;33(12):1673–6.CrossRefPubMed
14.
go back to reference Boddy K, Cowan K, Gibson A, Britten N. Does funded research reflect the priorities of people living with type 1 diabetes? A secondary analysis of research questions. BMJ Open. 2017;7(9):e016540.CrossRefPubMedPubMedCentral Boddy K, Cowan K, Gibson A, Britten N. Does funded research reflect the priorities of people living with type 1 diabetes? A secondary analysis of research questions. BMJ Open. 2017;7(9):e016540.CrossRefPubMedPubMedCentral
16.
go back to reference Aiyegbusi OL, McMullan C, Hughes SE, Turner GM, Subramanian A, Hotham R, et al. Considerations for patient and public involvement and engagement in health research. Nat Med. 2023;29(8):1922–9.CrossRefPubMed Aiyegbusi OL, McMullan C, Hughes SE, Turner GM, Subramanian A, Hotham R, et al. Considerations for patient and public involvement and engagement in health research. Nat Med. 2023;29(8):1922–9.CrossRefPubMed
18.
go back to reference Ng AH, Quigley M, Benson T, Cusack L, Hicks R, Nash B, et al. Living between two worlds: lessons for community involvement. Lancet Diabetes Endocrinol. 2024;12:155–7.CrossRefPubMed Ng AH, Quigley M, Benson T, Cusack L, Hicks R, Nash B, et al. Living between two worlds: lessons for community involvement. Lancet Diabetes Endocrinol. 2024;12:155–7.CrossRefPubMed
21.
go back to reference Bennett WL, Robinson KA, Saldanha IJ, Wilson LM, Nicholson WK. High priority research needs for gestational diabetes mellitus. J Womens Health. 2012;21(9):925–32.CrossRef Bennett WL, Robinson KA, Saldanha IJ, Wilson LM, Nicholson WK. High priority research needs for gestational diabetes mellitus. J Womens Health. 2012;21(9):925–32.CrossRef
22.
go back to reference Rees SE, Chadha R, Donovan LE, Guitard AL, Koppula S, Laupacis A, et al. Engaging patients and clinicians in establishing research priorities for gestational diabetes mellitus. Can J Diabetes. 2017;41(2):156–63.CrossRefPubMed Rees SE, Chadha R, Donovan LE, Guitard AL, Koppula S, Laupacis A, et al. Engaging patients and clinicians in establishing research priorities for gestational diabetes mellitus. Can J Diabetes. 2017;41(2):156–63.CrossRefPubMed
24.
go back to reference Brown K, Dyas J, Chahal P, Khalil Y, Riaz P, Cummings-Jones J. Discovering the research priorities of people with diabetes in a multicultural community: a focus group study. Br J Gen Pract. 2006;56(524):206–13.PubMedPubMedCentral Brown K, Dyas J, Chahal P, Khalil Y, Riaz P, Cummings-Jones J. Discovering the research priorities of people with diabetes in a multicultural community: a focus group study. Br J Gen Pract. 2006;56(524):206–13.PubMedPubMedCentral
25.
go back to reference Perrin BM, Raspovic A, Williams CM, Twigg SM, Golledge J, Hamilton EJ, et al. Establishing the national top 10 priority research questions to improve diabetes-related foot health and disease: a Delphi study of Australian stakeholders. BMJ Open Diabetes Res Care. 2021;9(2):e002570.CrossRefPubMedPubMedCentral Perrin BM, Raspovic A, Williams CM, Twigg SM, Golledge J, Hamilton EJ, et al. Establishing the national top 10 priority research questions to improve diabetes-related foot health and disease: a Delphi study of Australian stakeholders. BMJ Open Diabetes Res Care. 2021;9(2):e002570.CrossRefPubMedPubMedCentral
27.
go back to reference Sibbald SL, Singer PA, Upshur R, Martin DK. Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv Res. 2009;9(1):1–12.CrossRef Sibbald SL, Singer PA, Upshur R, Martin DK. Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv Res. 2009;9(1):1–12.CrossRef
29.
go back to reference Browne JL, Holmes-Truscott E, Ventura AD, Hendrieckx C, Pouwer F, Speight J. Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES: Australia (MILES-2) study. BMJ Open. 2017;7(2):e012926.CrossRefPubMedPubMedCentral Browne JL, Holmes-Truscott E, Ventura AD, Hendrieckx C, Pouwer F, Speight J. Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES: Australia (MILES-2) study. BMJ Open. 2017;7(2):e012926.CrossRefPubMedPubMedCentral
30.
go back to reference Brooks J, McCluskey S, Turley E, King N. The utility of template analysis in qualitative psychology research. Qual Res Psychol. 2015;12(2):202–22.CrossRefPubMed Brooks J, McCluskey S, Turley E, King N. The utility of template analysis in qualitative psychology research. Qual Res Psychol. 2015;12(2):202–22.CrossRefPubMed
32.
go back to reference Speight J, Choudhary P, Wilmot EG, Hendrieckx C, Forde H, Cheung WY, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40(1):e14944.CrossRefPubMed Speight J, Choudhary P, Wilmot EG, Hendrieckx C, Forde H, Cheung WY, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40(1):e14944.CrossRefPubMed
33.
go back to reference Choudhary P, Campbell F, Joule N, Kar P, Diabetes UK. A Type 1 diabetes technology pathway: consensus statement for the use of technology in type 1 diabetes. Diabet Med. 2019;36(5):531–8.CrossRefPubMed Choudhary P, Campbell F, Joule N, Kar P, Diabetes UK. A Type 1 diabetes technology pathway: consensus statement for the use of technology in type 1 diabetes. Diabet Med. 2019;36(5):531–8.CrossRefPubMed
34.
go back to reference Hunt D, Lamb K, Elliott J, Hemmingsen B, Slama S, Scibilia R, et al. A WHO key informant language survey of people with lived experiences of diabetes: media misconceptions, values-based messaging, stigma, framings and communications considerations. Diabetes Res Clin Pract. 2022;193:110109.CrossRefPubMed Hunt D, Lamb K, Elliott J, Hemmingsen B, Slama S, Scibilia R, et al. A WHO key informant language survey of people with lived experiences of diabetes: media misconceptions, values-based messaging, stigma, framings and communications considerations. Diabetes Res Clin Pract. 2022;193:110109.CrossRefPubMed
35.
go back to reference Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–51.CrossRefPubMed Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–51.CrossRefPubMed
36.
go back to reference Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–55.CrossRefPubMed Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–55.CrossRefPubMed
37.
go back to reference Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. 5-Year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol. 2024;12(4):233–46.CrossRefPubMed Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. 5-Year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol. 2024;12(4):233–46.CrossRefPubMed
38.
go back to reference Thom G, Messow CM, Leslie W, Barnes A, Brosnahan N, McCombie L, et al. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med. 2021;38(8):e14395.CrossRefPubMed Thom G, Messow CM, Leslie W, Barnes A, Brosnahan N, McCombie L, et al. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med. 2021;38(8):e14395.CrossRefPubMed
39.
go back to reference He J, Wang Y, Liu Y, Chen X, Bai J. Experiences of pregnant women with gestational diabetes mellitus: a systematic review of qualitative evidence protocol. BMJ Open. 2020;10(2):e034126.CrossRefPubMedPubMedCentral He J, Wang Y, Liu Y, Chen X, Bai J. Experiences of pregnant women with gestational diabetes mellitus: a systematic review of qualitative evidence protocol. BMJ Open. 2020;10(2):e034126.CrossRefPubMedPubMedCentral
40.
go back to reference Morrison MK, Lowe JM, Collins CE. Australian women’s experiences of living with gestational diabetes. Women Birth. 2014;27(1):52–7.CrossRefPubMed Morrison MK, Lowe JM, Collins CE. Australian women’s experiences of living with gestational diabetes. Women Birth. 2014;27(1):52–7.CrossRefPubMed
41.
go back to reference Rose MK, Costabile KA, Boland SE, Cohen RW, Persky S. Diabetes causal attributions among affected and unaffected individuals. BMJ Open Diabetes Res Care. 2019;7(1):e000708.CrossRefPubMedPubMedCentral Rose MK, Costabile KA, Boland SE, Cohen RW, Persky S. Diabetes causal attributions among affected and unaffected individuals. BMJ Open Diabetes Res Care. 2019;7(1):e000708.CrossRefPubMedPubMedCentral
42.
go back to reference Persky S, Costabile KA, Telaak SH. Diabetes causal attributions: pathways to stigma and health. Stigma Health. 2021;2021:896. Persky S, Costabile KA, Telaak SH. Diabetes causal attributions: pathways to stigma and health. Stigma Health. 2021;2021:896.
43.
go back to reference Hildebrandt T, Bode L, Ng JS. Effect of ‘lifestyle stigma’on public support for NHS-provisioned pre-exposure prophylaxis (PrEP) and preventative interventions for HPV and type 2 diabetes: a nationwide UK survey. BMJ Open. 2019;9(8):e029747.CrossRefPubMedPubMedCentral Hildebrandt T, Bode L, Ng JS. Effect of ‘lifestyle stigma’on public support for NHS-provisioned pre-exposure prophylaxis (PrEP) and preventative interventions for HPV and type 2 diabetes: a nationwide UK survey. BMJ Open. 2019;9(8):e029747.CrossRefPubMedPubMedCentral
44.
go back to reference Speight J, Holmes-Truscott E, Garza M, Scibilia R, Wagner S, Kato A, et al. Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. Lancet Diabet Endocrinol. 2024;12(1):61–82.CrossRef Speight J, Holmes-Truscott E, Garza M, Scibilia R, Wagner S, Kato A, et al. Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. Lancet Diabet Endocrinol. 2024;12(1):61–82.CrossRef
47.
go back to reference Holmes-Truscott E, Holloway EE, Lam B, Baptista S, Furler J, Hagger V, et al. ‘Is Insulin Right for Me?’: web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: a randomised controlled trial. Diabet Med. 2023;40(7):e15117.CrossRefPubMed Holmes-Truscott E, Holloway EE, Lam B, Baptista S, Furler J, Hagger V, et al. ‘Is Insulin Right for Me?’: web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: a randomised controlled trial. Diabet Med. 2023;40(7):e15117.CrossRefPubMed
Metadata
Title
Diabetes Research Matters: A Three-Round Priority-Setting Survey Consultation with Adults Living with Diabetes and Family Members in Australia
Authors
Christel Hendrieckx
Sienna Russell-Green
Timothy Skinner
Ashley H. Ng
Chris Lee
Siobhan Barlow
Alan Davey
Caitlin Rogers
Elizabeth Holmes-Truscott
Jane Speight
Publication date
06-04-2024
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-024-00688-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.